📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vaccinogen

1.1 - Company Overview

Vaccinogen Logo

Vaccinogen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vaccines and other immunotherapeutic products for cancers and infectious diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vaccinogen

Memo Therapeutics Logo

Memo Therapeutics

HQ: Switzerland Website
  • Description: Provider of antibody discovery and immune repertoire analysis, featuring the MemoMAB platform to create and bank recombinant copies of individual B cell/antibody repertoires for high-throughput functional screening to identify potent, ultra-rare antibodies. Offers human antibody repertoire libraries, discovery in humans and rabbits, and AntiBKV for BK virus in kidney transplant recipients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Memo Therapeutics company profile →
NewAmsterdam Pharma Logo

NewAmsterdam Pharma

HQ: The Netherlands Website
  • Description: Provider of clinical-stage research and development of therapies for cardio-metabolic diseases, including obicetrapib, a selective cholesteryl ester transfer protein (CETP) inhibitor that reduces LDL-C and increases HDL-C for treating metabolic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NewAmsterdam Pharma company profile →
RhoVac Logo

RhoVac

HQ: Denmark Website
  • Description: Provider of an immuno-oncology therapeutic cancer vaccine targeting metastatic cancer cells by recognizing RhoC-overexpressing cells to stimulate an immune response (RV001, in clinical trials), plus oncology technologies: iCIP (LiPlaCis + DRP to identify cisplatin responders and deliver the drug with higher efficacy and less toxicity), LiPlaCis (liposomal cisplatin), and DRP (mRNA-based predictor of cisplatin response).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RhoVac company profile →
Osivax Logo

Osivax

HQ: France Website
  • Description: Provider of immunotherapy vaccines powered by the oligoDOM self-assembling nanoparticle platform to elicit potent T- and B-cell responses and enable universal vaccines against mutating pathogens. Pipeline includes OVX836, a universal influenza A vaccine targeting nucleoprotein; OVX033, a universal sarbecovirus vaccine targeting nucleocapsid; and PANHPVAX, a pan-strain HPV vaccine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Osivax company profile →
Exacis Logo

Exacis

HQ: United States Website
  • Description: Provider of development-stage immuno-oncology solutions, using mRNA-based cell reprogramming to create iPSC and mRNA-based gene editing to engineer iPSC, creating engineered NK and T cells designed to resist host immune rejection to harness the human immune system against cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exacis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vaccinogen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vaccinogen

2.2 - Growth funds investing in similar companies to Vaccinogen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vaccinogen

4.2 - Public trading comparable groups for Vaccinogen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vaccinogen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vaccinogen

What does Vaccinogen do?

Vaccinogen is a provider of vaccines and other immunotherapeutic products for cancers and infectious diseases.

Who are Vaccinogen's competitors?

Vaccinogen's competitors and similar companies include Memo Therapeutics, NewAmsterdam Pharma, RhoVac, Osivax, and Exacis.

Where is Vaccinogen headquartered?

Vaccinogen is headquartered in United States.

How many employees does Vaccinogen have?

Vaccinogen has 1,000 employees 🔒.

When was Vaccinogen founded?

Vaccinogen was founded in 2010 🔒.

What sector and industry vertical is Vaccinogen in?

Vaccinogen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vaccinogen

Who are the top strategic acquirers in Vaccinogen's sector and industry

Top strategic M&A buyers and acquirers in Vaccinogen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vaccinogen?

Top strategic M&A buyers groups and sectors for Vaccinogen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vaccinogen's sector and industry vertical

Which are the top PE firms investing in Vaccinogen's sector and industry vertical?

Top PE firms investing in Vaccinogen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vaccinogen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vaccinogen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vaccinogen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vaccinogen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vaccinogen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vaccinogen?

The key public trading comparables and valuation benchmarks for Vaccinogen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vaccinogen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vaccinogen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vaccinogen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vaccinogen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vaccinogen's' sector and industry vertical?

Access recent funding rounds and capital raises in Vaccinogen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vaccinogen